✉news HealthMedicine first seen 14 h ago, last 11 h ago, peak #10
Immunis Named Semifinalist in $1.5 Million Healthy Longevity Competition
Original: Immunis Named Semifinalist in National Academy of Medicine’s $1.5 Million Healthy Longevity Global Competition Grand Prize
Biotech company Immunis has been named a semifinalist in the National Academy of Medicine's Healthy Longevity Global Competition, which awards a $1.5 million grand prize. The competition recognizes innovators working to extend healthy human lifespan, and Immunis advances alongside other selected candidates competing for the top award in the global longevity science field.
Why now: The National Academy of Medicine announced its latest semifinalists, drawing attention to companies working on healthy aging and longevity.
ImmunisNational Academy of MedicineHealthy Longevity Global Competition
Evidence
- Immunis Named Semifinalist in National Academy of Medicine’s $1.5 Million Healthy Longevity Global Competition Grand Prize · Business Wire
API: https://socialmediatrends-api.osmike.com/v1/trends/2120926